News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR childhood brain cancer research to benefit from funding boost announced by the Department of Health and Social Care and Cancer Research UK
Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK. The Institute of Cancer Research, London, will benefit from some of this new funding.
ICR teams up with Merck and Cancer Research UK on strategic drug discovery programme
The new alliance will take a strategic joint approach to drug discovery and build on previous successful collaborations on individual research projects.
Scientists reveal protein that all cells rely on to divide at the right time
ICR scientists have identified a cell cycle protein that is crucial to cell division, and whose location determines when cells begin to divide.
Sir Vince Cable MP visits The London Cancer Hub
Liberal Democrat leader Sir Vince Cable heard about exciting progress in delivery of The London Cancer Hub, and the challenges in taking advances in treatment to patients, during a visit to the ICR’s Sutton site.
Study opens up new way of treating rare cancer of arms and legs
The disease, called synovial sarcoma, showed unusual sensitivity to drugs that stop cells from repairing damage to their DNA.
Deal doubles land purchased for new London Cancer Hub
A new £14.1 million investment sets the stage for a site in Sutton, south London, to become the world’s leading hub for cancer research and treatment.
Discovery in understanding the spread of breast cancer could lead to new treatments to slow metastasis
Researchers have discovered a certain amino acid is essential for breast cancer spread and restricting it in mice can stop cancer cells invading other parts of the body.
Combination treatment blocks cell growth and triggers cell death in colon cancer
Drugs that block cancer’s growth and survival could be used in a powerful one-two combination with death-triggering cancer drugs to treat colon cancer, a new study shows.
ICR alumnus Professor Jacques Miller awarded the Japan Prize
Professor Jacques Miller has been awarded the prestigious Japan Prize for his discovery of the role of the thymus and the two types of white blood cell involved in the adaptive immune system – a discovery that laid the groundwork for much of the field of immunology.
Blocking cancer stress signal shows promise in bone marrow cancer
Potential new drugs that block a safeguard used by cancer cells to stay alive in stressful conditions have shown promise against myeloma, a cancer of white blood cells made in the bone marrow, a new study reports.
Blood test could indicate which patients will respond to immunotherapy
The test gives a measure of a patient’s immune system health by comparing the number of neutrophils with the number of lymphocytes.
.jpg?sfvrsn=2781c1a9_2 "Radiotherapy suite (4:3)")
Viral gene therapy could improve results from breast reconstruction surgery after cancer treatment
A new type of gene therapy delivered using a virus could protect healthy tissues from the harmful side-effects of radiotherapy after cancer treatment, a new study reports.
